INTERCEPT™ Blood System Approved in Brazil

The INTERCEPT™ Blood System for platelets and plasma has been approved for commercialisation in Brazil by the Agência Nacional de Vigilância Sanitária (ANVISA). This approval marks the first time that a system to inactivate pathogens in platelet and plasma components will be available in Brazil, representing a significant step towards proactive combat against transfusion-transmitted infections.